Search for: Search Or browse by category News Apr 09, 2021 Investor Webinar | Emyria and Cann Group Partnership Mar 28, 2021 Emyria and Cann Group to partner on Schedule 3 medicine CBD product registration Mar 20, 2021 Opinion | Psychedelic substances represent a chance to alleviate Australia’s mental health crisis Mar 16, 2021 Presentation: Dr Michael Winlo on Broker Briefing Feb 22, 2021 Dr Karen Smith appointed Chair of Emyria’s Strategic Advisory Board Feb 10, 2021 Emyria adds second Melbourne clinic ahead of EMD-003 registration trials Feb 10, 2021 Emyria wins digital health monitoring grant with University of Western Australia Feb 02, 2021 Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter Feb 02, 2021 Emyria adds Naval Veteran and consultant psychiatrist to their Medical Advisory Board
